← Bausch Health Companies Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $542.0m | $720.0m | $721.0m | $3.2b | $605.0m | $582.0m | $564.0m | $947.0m | $1.2b | $1.3b | |
| Prepaid Expense and Other Assets, Current | $696.0m | $771.0m | $689.0m | $779.0m | $855.0m | $720.0m | $776.0m | $1.1b | $838.0m | $852.0m | |
| Inventory, Net | $1.1b | $1.0b | $934.0m | $1.1b | $1.1b | $993.0m | $1.1b | $1.5b | $1.6b | $1.6b | |
| Assets, Current | $5.1b | $4.7b | $4.2b | $7.0b | $5.3b | $5.6b | $4.2b | $5.6b | $5.8b | $6.2b | |
| Property, Plant and Equipment, Net | $1.3b | $1.4b | $1.4b | $1.5b | $1.6b | $1.6b | $1.6b | $1.7b | $1.8b | $2.1b | |
| Goodwill | $15.8b | $15.6b | $13.1b | $13.1b | $13.0b | $12.5b | $11.5b | $11.2b | $11.1b | $11.3b | |
| Intangible Assets, Net (Excluding Goodwill) | $18.9b | $15.2b | $12.0b | $10.2b | $8.4b | $6.9b | $5.8b | $6.5b | $5.6b | $4.6b | |
| Operating Lease, Right-of-Use Asset | — | — | — | $271.0m | $259.0m | $247.0m | $221.0m | $185.0m | $211.0m | $215.0m | |
| Other Assets, Noncurrent | $184.0m | $99.0m | $109.0m | $411.0m | $664.0m | $340.0m | $326.0m | $307.0m | $363.0m | $378.0m | |
| Additional Financial Items | |||||||||||
| Accrued Liabilities, Current | $3.2b | $3.7b | $3.2b | $4.5b | $4.6b | $4.8b | $3.0b | $3.1b | $3.4b | $3.3b | |
| Assets | $43.5b | $37.5b | $32.5b | $33.9b | $31.2b | $29.2b | $25.7b | $27.4b | $26.5b | $26.4b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $53.0m | $52.0m | $50.0m | $50.0m | $61.0m | $58.0m | $61.0m | |
| Accounts Payable, Current | $324.0m | $365.0m | $411.0m | $503.0m | $337.0m | $407.0m | $521.0m | $719.0m | $656.0m | $600.0m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $240.0m | $227.0m | $214.0m | $184.0m | $148.0m | $165.0m | $167.0m | |
| Long-term Debt, Excluding Current Maturities | $29.8b | $25.2b | $24.1b | $24.7b | $23.9b | $22.7b | $20.3b | $21.9b | $18.9b | $20.6b | |
| Long-term Debt, Current Maturities | $1.0m | $209.0m | $228.0m | $1.2b | $0 | $0 | $432.0m | $450.0m | $2.7b | $225.0m | |
| Liabilities, Current | $3.6b | $4.3b | $3.8b | $6.2b | $4.9b | $5.2b | $3.9b | $4.3b | $6.8b | $4.2b | |
| Deferred Income Tax Liabilities, Net | — | $1.2b | $885.0m | $705.0m | $528.0m | $529.0m | $202.0m | $163.0m | $128.0m | $147.0m | |
| Other Liabilities, Noncurrent | $107.0m | $526.0m | $581.0m | $851.0m | $1.0b | $653.0m | $741.0m | $776.0m | $713.0m | $793.0m | |
| Deferred Tax Liabilities, Net | $5.3b | $747.0m | $885.0m | $705.0m | $528.0m | $529.0m | $202.0m | $163.0m | $128.0m | $147.0m | |
| Liabilities | $40.3b | $31.6b | $29.7b | $32.7b | $30.6b | $29.2b | $25.4b | $27.4b | $26.8b | $26.0b | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $10.0b | $10.1b | $10.1b | $10.2b | $10.2b | $10.3b | $10.4b | $10.4b | $10.5b | $10.5b | |
| Retained Earnings (Accumulated Deficit) | ($5.1b) | ($2.7b) | ($5.7b) | ($7.5b) | ($8.0b) | ($9.0b) | ($9.2b) | ($9.8b) | ($9.8b) | ($9.7b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($2.1b) | ($1.9b) | ($2.1b) | ($2.1b) | ($2.1b) | ($1.9b) | ($2.1b) | ($1.9b) | ($2.2b) | ($1.8b) | |
| Additional Paid in Capital, Common Stock | $351.0m | $380.0m | $413.0m | $429.0m | $454.0m | $462.0m | $159.0m | $214.0m | $234.0m | $357.0m | |
| Stockholders' Equity Attributable to Parent | $3.2b | $5.8b | $2.7b | $1.1b | $535.0m | ($106.0m) | ($692.0m) | ($1.0b) | ($1.3b) | ($554.0m) | |
| Stockholders' Equity Attributable to Noncontrolling Interest | $106.0m | $95.0m | $82.0m | $73.0m | $70.0m | $72.0m | $952.0m | $940.0m | $957.0m | $931.0m | |
| Liabilities and Equity | $43.5b | $37.5b | $32.5b | $33.9b | $31.2b | $29.2b | $25.7b | $27.4b | $26.5b | $26.4b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.